Ryan Edward Brown, EVP, General Counsel at Sarepta Therapeutics, Inc. (SRPT), sold 80,266 shares at $164.52 ($13.0M) on 2024-06-25, disclosed to the SEC on 2024-06-25.
Scheduled sale ($13.0M) by EVP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $164.64 | 2,352 | $387K | 3.0% |
| 2 | $158.07 | 7,644 | $1.2M | 9.3% |
| 3 | $158.07 | 7,644 | $1.2M | 9.3% |
| 4 | $159.14 | 2,200 | $350K | 2.7% |
| 5 | $159.14 | 2,200 | $350K | 2.7% |
| 6 | $160.31 | 975 |
| $156K |
| 1.2% |
| 7 | $160.31 | 975 | $156K | 1.2% |
| 8 | $161.82 | 4,168 | $674K | 5.2% |
| 9 | $161.82 | 4,168 | $674K | 5.2% |
| 10 | $162.65 | 17,581 | $2.9M | 22.0% |
| 11 | $162.65 | 17,581 | $2.9M | 22.0% |
| 12 | $163.53 | 3,840 | $628K | 4.8% |
| 13 | $163.53 | 3,840 | $628K | 4.8% |
| 14 | $164.52 | 2,549 | $419K | 3.2% |
| 15 | $164.52 | 2,549 | $419K | 3.2% |
| Total | $161.70 avg | 80,266 | $13.0M | 100% |